39 related articles for article (PubMed ID: 16371801)
1. Efficacy of Rituximab on Refractory Organ Involvements in Granulomatosis with Polyangiitis: A Systematic Review of Case Reports.
Hajishah H; Amini MJ; Chadeganipour AS; Salehi SA; Kazemi D
Curr Rheumatol Rev; 2024; 20(3):270-283. PubMed ID: 37907486
[TBL] [Abstract][Full Text] [Related]
2. The Efficacy and Safety of Rituximab in ANCA-Associated Vasculitis: A Systematic Review.
Habibi MA; Alesaeidi S; Zahedi M; Hakimi Rahmani S; Piri SM; Tavakolpour S
Biology (Basel); 2022 Dec; 11(12):. PubMed ID: 36552276
[No Abstract] [Full Text] [Related]
3. Granulomatosis with Polyangiitis Complicated by Hypertrophic Pachymeningitis Presenting with Simultaneous Multiple Intracerebral Hemorrhages.
Kato E; Tahara K; Hayashi H; Shoji A; Mori H; Sawada T
Intern Med; 2018 Apr; 57(8):1167-1172. PubMed ID: 29279498
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapies for Neurological Manifestations in the Context of Systemic Autoimmunity.
Kampylafka EI; Alexopoulos H; Dalakas MC; Tzioufas AG
Neurotherapeutics; 2016 Jan; 13(1):163-78. PubMed ID: 26510559
[TBL] [Abstract][Full Text] [Related]
5. Toxicities of immunosuppressive treatment of autoimmune neurologic diseases.
Lallana EC; Fadul CE
Curr Neuropharmacol; 2011 Sep; 9(3):468-77. PubMed ID: 22379461
[TBL] [Abstract][Full Text] [Related]
6. Analysis of Wegener's granulomatosis responses to rituximab: current evidence and therapeutic prospects.
Aouba A; Pagnoux C; Bienvenu B; Mahr A; Guillevin L
Clin Rev Allergy Immunol; 2008 Feb; 34(1):65-73. PubMed ID: 18270860
[TBL] [Abstract][Full Text] [Related]
7. Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2007.
Furst DE; Breedveld FC; Kalden JR; Smolen JS; Burmester GR; Sieper J; Emery P; Keystone EC; Schiff MH; Mease P; van Riel PL; Fleischmann R; Weisman MH; Weinblatt ME
Ann Rheum Dis; 2007 Nov; 66 Suppl 3(Suppl 3):iii2-22. PubMed ID: 17934088
[No Abstract] [Full Text] [Related]
8. [Treatment of ANCA-associated vascularitides].
Guillevin L; Pagnoux C
Presse Med; 2007 May; 36(5 Pt 2):922-7. PubMed ID: 17408912
[TBL] [Abstract][Full Text] [Related]
9. Rituximab (MABTHERA) and severe polyangiitis. An option for patients informed of the uncertainties.
Prescrire Int; 2015 Jun; 24(161):145-8. PubMed ID: 26436161
[TBL] [Abstract][Full Text] [Related]
10. Wegener granulomatosis with massive intracerebral hemorrhage: remission of disease in response to rituximab.
Memet B; Rudinskaya A; Krebs T; Oelberg D
J Clin Rheumatol; 2005 Dec; 11(6):314-8. PubMed ID: 16371801
[TBL] [Abstract][Full Text] [Related]
11. Massive intracerebral hemorrhage associated with Wegener granulomatosis.
Ceri M; Ortabozkoyun L; Unverdi S; Kirac M; Duranay M
Rheumatol Int; 2012 Jun; 32(6):1813-4. PubMed ID: 21594720
[TBL] [Abstract][Full Text] [Related]
12. Rituximab for severe refractory pediatric Wegener granulomatosis.
Patel AM; Lehman TJ
J Clin Rheumatol; 2008 Oct; 14(5):278-80. PubMed ID: 18824926
[TBL] [Abstract][Full Text] [Related]
13. Wegener granulomatosis (granulomatosis with polyangiitis): evolving concepts in treatment.
Lynch JP; Tazelaar H
Semin Respir Crit Care Med; 2011 Jun; 32(3):274-97. PubMed ID: 21674414
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
